News

Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient with Inconclusive Imaging
SAN ANTONIO, July 09, 2025--bioAffinity Technologies' CyPath® Lung detects Stage 1A lung cancer when imaging was inconclusive ...
Never smoked? You could still be at risk of developing lung cancer, doctors warn
Medical experts report rising lung cancer diagnoses in non-smokers as smoking rates decline, raising questions about ...
Real-time trial shows AI could speed cancer care
A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...
Knowridge Science Report10d
Lung cancer without smoking: signs you shouldn’t ignore
Because people don’t expect to get lung cancer without a smoking history, symptoms are often ignored or misdiagnosed as ...
Physician's Weekly4d
Rosmarinic acid potentiates gefitinib in lung adenocarcinoma by modulating interactions between cancer cells and cancer-associated fibroblasts.
While cancer-associated fibroblasts (CAFs) significantly influence tumor progression, their temporal dynamics remain poorly understood. We investigated time-dependent interactions between non-small ...
Why newly diagnosed lung cancer patients should get this test done before starting treatment
Nearly a quarter of all newly diagnosed patients with advanced lung cancer are not given a test that could improve their chances for long-term survival and reduce their side effects.